Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Central control of bone remodeling.

Shu Takeda1

  • 1Department of Orthopedics, 21st Century Center of Excellence (COE) Program for Frontier Research on Molecular Destruction and Reconstruction of Tooth and Bone, Tokyo Medical and Dental University Graduate School, Tokyo, Japan. shu-tky@umin.ac.jp

Biochemical and Biophysical Research Communications
|February 8, 2005
PubMed
Summary

Leptin centrally regulates bone mass by inhibiting osteoblast activity via the sympathetic nervous system. Blocking beta-adrenergic receptors increases bone mass, highlighting a novel therapeutic target for bone diseases.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Latent metabolic bone disease, skeletal dysplasia and other conditions related to low bone formation among 38 patients with subtrochanteric femoral fractures: a retrospective observational study.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2024
Same author

A Novel Long Noncoding RNA in Osteocytes Regulates Bone Formation through the Wnt/β-Catenin Signaling Pathway.

International journal of molecular sciences·2023
Same author

Three-dimensional visualization of neural networks inside bone by Osteo-DISCO protocol and alteration of bone remodeling by surgical nerve ablation.

Scientific reports·2023
Same author

Runx1 and Runx2 inhibit fibrotic conversion of cellular niches for hematopoietic stem cells.

Nature communications·2022
Same author

Epigenetic regulator UHRF1 orchestrates proinflammatory gene expression in rheumatoid arthritis in a suppressive manner.

The Journal of clinical investigation·2022
Same author

Mechanical load regulates bone growth via periosteal Osteocrin.

Cell reports·2021

Area of Science:

  • Endocrinology
  • Neuroscience
  • Bone Biology

Background:

  • Hormonal regulation of osteoblast activity is a long-standing area of research.
  • Leptin has been investigated for its potential role in central bone mass regulation.

Purpose of the Study:

  • To investigate leptin's role as a central regulator of bone formation.
  • To identify the peripheral mediators of leptin's effects on bone mass.

Main Methods:

  • Intracerebroventricular infusion of leptin in animal models.
  • Analysis of bone mass in catecholamine-deficient mice.
  • Administration of beta-receptor agonists and beta-blockers.

Main Results:

  • Central leptin infusion decreased bone mass, indicating central regulation.

Related Experiment Videos

  • The sympathetic nervous system mediates leptin's effect on bone.
  • Catecholamine deficiency led to increased bone mass.
  • Beta-blocker treatment increased bone mass, while agonists decreased it.

    • Conclusions:

    • Leptin is a key central regulator of bone mass.
    • The sympathetic nervous system is a critical peripheral mediator of leptin's skeletal actions.
    • Beta-adrenergic signaling represents a potential therapeutic target for modulating bone mass.